KRMD's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 167 similar instances where the Aroon Indicator showed a similar pattern. In 144 of the 167 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 59 cases where KRMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for KRMD just turned positive on October 12, 2026. Looking at past instances where KRMD's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
KRMD moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KRMD crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +6.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRMD advanced for three days, in 178 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KRMD as a result. In 96 of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
KRMD broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.904) is normal, around the industry mean (4.964). KRMD has a moderately low P/E Ratio (-77.250) as compared to the industry average of (40.591). Projected Growth (PEG Ratio) (1.770) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.292) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. KRMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
QDEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 45 cases where QDEL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where QDEL's RSI Indicator exited the oversold zone, 34 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for QDEL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +2.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where QDEL advanced for three days, in 176 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 113 of 153 cases where QDEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QDEL as a result. In 73 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for QDEL turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 36 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
QDEL moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QDEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.413) is normal, around the industry mean (4.142). P/E Ratio (-0.693) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.274) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. QDEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QDEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KRMD | QDEL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 90 | 100 | |
SMR RATING 1..100 | 94 | 98 | |
PRICE GROWTH RATING 1..100 | 58 | 62 | |
P/E GROWTH RATING 1..100 | 18 | 13 | |
SEASONALITY SCORE 1..100 | 90 | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KRMD's Valuation (7) in the null industry is in the same range as QDEL (30) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.
KRMD's Profit vs Risk Rating (90) in the null industry is in the same range as QDEL (100) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.
KRMD's SMR Rating (94) in the null industry is in the same range as QDEL (98) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.
KRMD's Price Growth Rating (58) in the null industry is in the same range as QDEL (62) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to QDEL’s over the last 12 months.
QDEL's P/E Growth Rating (13) in the Medical Specialties industry is in the same range as KRMD (18) in the null industry. This means that QDEL’s stock grew similarly to KRMD’s over the last 12 months.
| KRMD | QDEL | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 80% |
| Advances ODDS (%) | 3 days ago 78% | 8 days ago 67% |
| Declines ODDS (%) | 27 days ago 81% | 6 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 74% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KRMD’s FA Score shows that 2 FA rating(s) are green while QDEL’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KRMD’s TA Score shows that 6 TA indicator(s) are bullish while QDEL’s TA Score has 6 bullish TA indicator(s).
KRMD (@Pharmaceuticals: Other) experienced а +1.94% price change this week, while QDEL (@Medical/Nursing Services) price change was -18.24% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
KRMD is expected to report earnings on Mar 17, 2027.
QDEL is expected to report earnings on Feb 17, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.
| Ticker / NAME | Correlation To KRMD | 1D Price Change % | ||
|---|---|---|---|---|
| KRMD | 100% | -2.17% | ||
| QDEL - KRMD | 40% Loosely correlated | -4.71% | ||
| A - KRMD | 40% Loosely correlated | -1.27% | ||
| CLPT - KRMD | 39% Loosely correlated | -4.36% | ||
| BIO - KRMD | 38% Loosely correlated | -0.47% | ||
| NVST - KRMD | 35% Loosely correlated | -0.50% | ||
More | ||||
A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then AZTA could also see price increases.
| Ticker / NAME | Correlation To QDEL | 1D Price Change % | ||
|---|---|---|---|---|
| QDEL | 100% | -4.71% | ||
| AZTA - QDEL | 51% Loosely correlated | -1.15% | ||
| XRAY - QDEL | 50% Loosely correlated | +1.68% | ||
| RVTY - QDEL | 50% Loosely correlated | -1.01% | ||
| DHR - QDEL | 49% Loosely correlated | +0.42% | ||
| A - QDEL | 48% Loosely correlated | -1.27% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SARK | 26.77 | 0.67 | +2.57% |
| Tradr 1X Short Innovation Daily ETF (SARK) | |||
| EPMB | 26.41 | N/A | N/A |
| Harbor Mid Cap Core ETF | |||
| TAXE | 50.34 | -0.16 | -0.31% |
| T. Rowe Price Intermediate Municipal Income ETF (TAXE) | |||
| CGIC | 35.21 | -0.21 | -0.59% |
| Capital Group International Core Equity ETF (CGIC) | |||
| OAEM | 44.07 | -0.37 | -0.83% |
| OneAscent Enhanced Small and Mid Cap ETF Institutional Shs OneAscent Emerging Markets Fund (OAEM) | |||